The hepatitis B virus is an important cause of acute and chronic liver disease. It is also the most common form of parenterally transmitted viral hepatitis. The virus is estimated to affect some 350 million people worldwide. Immunization against hepatitis B is an important component of preventative medicine and is offered to all children in approximately 30 countries.
Hepatitis B virus (HBV) belongs to the Hepadnaviridae family and infection with HBV is usually more serious than infection with hepatitis A virus. In some individuals the infection is not cleared and followed by persistent intracellular viral carriage that can lead to the development of hepatocelular carcinomas. There are currently 400 million HBV carriers worldwide making HBV one of the most common human pathogens.
Recombinant Hepatitis B Surface Antigen ayw (S region) is a 24kD protein. Does not contain a fusion partner.
Applications:
Suitable for use in ELISA or for antigen applications in Immunological protocols. Other applications not tested.
Recommended Dilutions:
Optimal dilutions to be determined by the researcher.
Storage and Stability:
May be stored at 4 degrees C. For long-term storage, aliquot and store at 4 degrees C. Do not freeze. Aliquots are stable for 6 months. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.
Also Available:
H1909-17: Hepatitis B Surface Antigen adr, Recombinant (HBsAg adr)
H1909-18: Hepatitis B Surface Antigen adw, Recombinant (HBsAg adw)
H1909-22: Hepatitis B Surface Antigen ayw, Recombinant (HBsAg ayw)